Clinically important differences in health-related quality of life for patients with asthma: An expert consensus panel report

Kathleen W. Wyrwich, Harold S. Nelson, William M. Tierney, Ajit N. Babu, Kurt Kroenke, Fredric D. Wolinsky

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Background: Standards for change in health-related quality of life (HRQoL) measures used among asthmatic patients have been established by considering only patient preferences to determine important differences and may not reflect an informed clinical evaluation of change. Objective: To establish clinically important difference (CID) standards through the consensus of an expert physician panel for the Juniper Asthma Quality of Life Questionnaire (AQLQ) and Medical Outcomes Study Short-Form 36-Item Health Survey (SF-36, version 2) when used to measure HRQoL among asthmatic patients. Methods: We organized an 8-person panel of physicians familiar with measuring HRQoL among asthmatic patients with the AQLQ and the SF-36. This expert panel participated in 2 rounds of a modified Delphi process before attending an in-person consensus meeting to establish the CID standards for small, moderate, and large changes in the AQLQ and the SF-36. After the consensus meeting, the panel used an iterative improvement process to cooperatively complete their final report. Results: The expert panel's thresholds for detecting CIDs in the domains of the AQLQ were much higher than previously established levels using patient-perceived changes. CIDs for asthma were also ascertained on the scales of the SF-36, version 2, which were markedly greater than previously cited cross-sectional differences between patient groups. Conclusions: The CID standards established by this expert panel elucidate a potential distinction between patient and physician perspectives of important HRQoL changes. The many stakeholders of HRQoL difference standards should consider this distinction when adopting standards to evaluate patient change.

Original languageEnglish
Pages (from-to)148-153
Number of pages6
JournalAnnals of Allergy, Asthma and Immunology
Volume91
Issue number2
StatePublished - Aug 1 2003

Fingerprint

Asthma
Quality of Life
Physicians
Juniperus
Patient Preference
Health Surveys
Outcome Assessment (Health Care)
Surveys and Questionnaires

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Clinically important differences in health-related quality of life for patients with asthma : An expert consensus panel report. / Wyrwich, Kathleen W.; Nelson, Harold S.; Tierney, William M.; Babu, Ajit N.; Kroenke, Kurt; Wolinsky, Fredric D.

In: Annals of Allergy, Asthma and Immunology, Vol. 91, No. 2, 01.08.2003, p. 148-153.

Research output: Contribution to journalArticle

Wyrwich, Kathleen W. ; Nelson, Harold S. ; Tierney, William M. ; Babu, Ajit N. ; Kroenke, Kurt ; Wolinsky, Fredric D. / Clinically important differences in health-related quality of life for patients with asthma : An expert consensus panel report. In: Annals of Allergy, Asthma and Immunology. 2003 ; Vol. 91, No. 2. pp. 148-153.
@article{eb69a7d063744d5780f0abbaf612ea5e,
title = "Clinically important differences in health-related quality of life for patients with asthma: An expert consensus panel report",
abstract = "Background: Standards for change in health-related quality of life (HRQoL) measures used among asthmatic patients have been established by considering only patient preferences to determine important differences and may not reflect an informed clinical evaluation of change. Objective: To establish clinically important difference (CID) standards through the consensus of an expert physician panel for the Juniper Asthma Quality of Life Questionnaire (AQLQ) and Medical Outcomes Study Short-Form 36-Item Health Survey (SF-36, version 2) when used to measure HRQoL among asthmatic patients. Methods: We organized an 8-person panel of physicians familiar with measuring HRQoL among asthmatic patients with the AQLQ and the SF-36. This expert panel participated in 2 rounds of a modified Delphi process before attending an in-person consensus meeting to establish the CID standards for small, moderate, and large changes in the AQLQ and the SF-36. After the consensus meeting, the panel used an iterative improvement process to cooperatively complete their final report. Results: The expert panel's thresholds for detecting CIDs in the domains of the AQLQ were much higher than previously established levels using patient-perceived changes. CIDs for asthma were also ascertained on the scales of the SF-36, version 2, which were markedly greater than previously cited cross-sectional differences between patient groups. Conclusions: The CID standards established by this expert panel elucidate a potential distinction between patient and physician perspectives of important HRQoL changes. The many stakeholders of HRQoL difference standards should consider this distinction when adopting standards to evaluate patient change.",
author = "Wyrwich, {Kathleen W.} and Nelson, {Harold S.} and Tierney, {William M.} and Babu, {Ajit N.} and Kurt Kroenke and Wolinsky, {Fredric D.}",
year = "2003",
month = "8",
day = "1",
language = "English",
volume = "91",
pages = "148--153",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "2",

}

TY - JOUR

T1 - Clinically important differences in health-related quality of life for patients with asthma

T2 - An expert consensus panel report

AU - Wyrwich, Kathleen W.

AU - Nelson, Harold S.

AU - Tierney, William M.

AU - Babu, Ajit N.

AU - Kroenke, Kurt

AU - Wolinsky, Fredric D.

PY - 2003/8/1

Y1 - 2003/8/1

N2 - Background: Standards for change in health-related quality of life (HRQoL) measures used among asthmatic patients have been established by considering only patient preferences to determine important differences and may not reflect an informed clinical evaluation of change. Objective: To establish clinically important difference (CID) standards through the consensus of an expert physician panel for the Juniper Asthma Quality of Life Questionnaire (AQLQ) and Medical Outcomes Study Short-Form 36-Item Health Survey (SF-36, version 2) when used to measure HRQoL among asthmatic patients. Methods: We organized an 8-person panel of physicians familiar with measuring HRQoL among asthmatic patients with the AQLQ and the SF-36. This expert panel participated in 2 rounds of a modified Delphi process before attending an in-person consensus meeting to establish the CID standards for small, moderate, and large changes in the AQLQ and the SF-36. After the consensus meeting, the panel used an iterative improvement process to cooperatively complete their final report. Results: The expert panel's thresholds for detecting CIDs in the domains of the AQLQ were much higher than previously established levels using patient-perceived changes. CIDs for asthma were also ascertained on the scales of the SF-36, version 2, which were markedly greater than previously cited cross-sectional differences between patient groups. Conclusions: The CID standards established by this expert panel elucidate a potential distinction between patient and physician perspectives of important HRQoL changes. The many stakeholders of HRQoL difference standards should consider this distinction when adopting standards to evaluate patient change.

AB - Background: Standards for change in health-related quality of life (HRQoL) measures used among asthmatic patients have been established by considering only patient preferences to determine important differences and may not reflect an informed clinical evaluation of change. Objective: To establish clinically important difference (CID) standards through the consensus of an expert physician panel for the Juniper Asthma Quality of Life Questionnaire (AQLQ) and Medical Outcomes Study Short-Form 36-Item Health Survey (SF-36, version 2) when used to measure HRQoL among asthmatic patients. Methods: We organized an 8-person panel of physicians familiar with measuring HRQoL among asthmatic patients with the AQLQ and the SF-36. This expert panel participated in 2 rounds of a modified Delphi process before attending an in-person consensus meeting to establish the CID standards for small, moderate, and large changes in the AQLQ and the SF-36. After the consensus meeting, the panel used an iterative improvement process to cooperatively complete their final report. Results: The expert panel's thresholds for detecting CIDs in the domains of the AQLQ were much higher than previously established levels using patient-perceived changes. CIDs for asthma were also ascertained on the scales of the SF-36, version 2, which were markedly greater than previously cited cross-sectional differences between patient groups. Conclusions: The CID standards established by this expert panel elucidate a potential distinction between patient and physician perspectives of important HRQoL changes. The many stakeholders of HRQoL difference standards should consider this distinction when adopting standards to evaluate patient change.

UR - http://www.scopus.com/inward/record.url?scp=0041488673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041488673&partnerID=8YFLogxK

M3 - Article

C2 - 12952108

AN - SCOPUS:0041488673

VL - 91

SP - 148

EP - 153

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

SN - 1081-1206

IS - 2

ER -